FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.
An analysis of national search trends and surgeon workforce data highlights rising patient interest in aesthetic procedures across Southern, Midwestern, and rural regions where access to board-certified plastic surgeons remains limited.